Last update 11 Jul 2024
Sorrento Therapeutics, Inc.

Sorrento Therapeutics, Inc.

Public Company|
2006|
California, United States
|
500-1,000
| OTC: SRNE|

Overview

Basic Info

Introduction
Sorrento Therapeutics is a biopharmaceutical company that specializes in discovering, developing, and commercializing proprietary drug therapies to address significant unmet medical needs. Sorrento has a diverse antibody library comprised of high-quality, fully human antibodies with a diversity of more than ten trillion (>10^16). The company has all the necessary in-house capabilities to generate and develop a new generation of homogenous antibody-drug conjugates (ADCs) with well-defined drug antibody ratios (DAR) in contrast to approved ADCs, which are heterogeneous mixtures with different DARs. Sorrento's primary therapeutic focus is cancer, but its products and technologies have broader clinical applications, including autoimmune disorders, metabolic diseases, and infectious diseases.

Tags

Neoplasms
Respiratory Diseases
Infectious Diseases
Small molecule drug
Antibody drug conjugate (ADC)
Monoclonal antibody

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Top 5 Drug TypeCount
Small molecule drug14
Antibody drug conjugate (ADC)11
Monoclonal antibody9
Cell therapy8
Fusion protein1

Corporation Tree

Boost your research with our corporation tree data.
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 20 Jul 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Discovery
2
31
Preclinical
Phase 1 Clinical
10
5
Phase 2 Clinical
Phase 3 Clinical
2
3
Approved
Other
29
Login to view more data

Current Projects

Login to view more data

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free